Incyte to Report First Quarter Financial Results
Get Alerts INCY Hot Sheet
Join SI Premium – FREE
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 5, 2020.
The schedule for the press release and conference call/webcast is as follows:
|
May 5, 2020 at 7:00 a.m. ET |
||
|
May 5, 2020 at 8:00 a.m. ET |
||
|
877-407-3042 |
||
|
201-389-0864 |
||
|
13702083 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13702083.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200416005010/en/
Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
[email protected]
Investors
Michael Booth, DPhil
+1 302 498 5914
[email protected]
Source: Incyte
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Natuzzi Celebrates Its 65th Anniversary by Bringing Its Harmony and Its New Collections on the Stage of the High Point Market in US and of the Design Week in Milan
- Faraday Future Receives Letter from Nasdaq Regarding Form 10-K Filing
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!